Petrolatum ointment

DRUG6 trials

Sponsors

Northwestern University, LEO Pharma, The University of Texas Health Science Center, Houston, Turn Therapeutics, Indonesia University

Conditions

AcrochordonAtopic DermatitisCovid19Forehead RhytidesForehead WrinklesPsoriasis VulgarisSeborrheic KeratosisSkin and Connective Tissue Diseases

Phase 1

Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100

CompletedNCT01935869

LEO PharmaPsoriasis Vulgaris

Start: 2013-08-31End: 2013-12-31Updated: 2025-02-24

A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin

CompletedNCT02355639

LEO PharmaSkin and Connective Tissue Diseases

Start: 2015-01-31End: 2015-04-30Updated: 2025-02-24

Phase 2

Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.

CompletedNCT04951349

Turn TherapeuticsCovid19

Start: 2021-01-21End: 2021-05-30Updated: 2021-07-06

Phase 4

The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis

CompletedNCT00179959

Northwestern UniversityAtopic Dermatitis

Start: 2005-09-30End: 2011-03-31Updated: 2014-12-08

Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum Ointment

CompletedNCT03799484

The University of Texas Health Science Center, HoustonForehead Rhytides, Forehead Wrinkles

Start: 2019-01-04End: 2019-06-14Updated: 2020-06-18

Unknown Phase

Effectiveness of Sodium Fusidate Ointment Compared to Petrolatum for Wound Healing Following Cauterization

CompletedNCT05353374

Indonesia UniversityAcrochordon, Seborrheic Keratosis

Start: 2021-01-01End: 2021-05-31Updated: 2022-05-05

Related Papers

Comparing Sodium Fusidate and Petrolatum for Electrosurgery-related Wound Healing: A Double-blind Randomized Controlled Trial

Journal of General-Procedural Dermatology & Venereology Indonesia2025-06-26